Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pfizer's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
25.90 +0.04    +0.15%
06:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
25.93
+0.03
+0.12%
9:59:33 - Real-time Data
  • Volume: 28,620,603
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 25.75 - 26.17
Type:  Equity
Market:  United States
Pfizer 25.90 +0.04 +0.15%

PFE Financial Summary

 
A brief financial summary of Pfizer Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Pfizer Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 1,910 million compared to USD 2,217 million a year ago. Revenue was USD 14,249 million compared to USD 24,290 million a year ago. Net loss was USD 3,369 million compared to net income of USD 4,995 million a year ago. Basic loss per share from continuing operations was USD 0.59 compared to basic earnings per share from continuing operations of USD 0.89 a year ago. Diluted loss per share from continuing operations was USD 0.59 compared to diluted earnings per share from continuing operations of USD 0.87 a year ago. Basic loss per share was USD 0.6 compared to basic earnings per share of USD 0.89 a year ago. Diluted loss per share was USD 0.6 compared to diluted earnings per share of USD 0.87 a year ago.For the full year, revenue was USD 58,496 million compared to USD 100,330 million a year ago. Net income was USD 2,119 million compared to USD 31,372 million a year ago. Basic earnings per share from continuing operations was USD 0.38 compared to USD 5.59 a year ago. Diluted earnings per share from continuing operations was USD 0.37 compared to USD 5.47 a year ago. Basic earnings per share was USD 0.38 compared to USD 5.59 a year ago. Diluted earnings per share was USD 0.37 compared to USD 5.47 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

PFE Income Statement

Gross margin TTM 58.99%
Operating margin TTM 8.99%
Net Profit margin TTM 3.62%
Return on Investment TTM 3.02%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Oct 01, 2023 Jul 02, 2023 Apr 02, 2023
Total Revenue 14249 13232 12734 18282
Gross Profit 1135 9927 9802 13535
Operating Income -7120 2954 2657 6662
Net Income -3369 -2382 2327 5543

PFE Balance Sheet

Quick Ratio MRQ 0.5
Current Ratio MRQ 0.91
LT Debt to Equity MRQ 69.44%
Total Debt to Equity MRQ 84.63%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Oct 01, 2023 Jul 02, 2023 Apr 02, 2023
Total Assets 226501 215021 220168 195617
Total Liabilities 137213 117817 120875 94381
Total Equity 89288 97204 99293 101236

PFE Cash Flow Statement

Cash Flow/Share TTM 1.54
Revenue/Share TTM 10.36
Operating Cash Flow  10.96%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Oct 01, 2023 Jul 02, 2023 Apr 02, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 5240 -1208 1212
Cash From Investing Activities -10996 -25485 3315
Cash From Financing Activities 5442 27174 -2771
Net Change in Cash -317 475 1754
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andrzej Bagiński
Andrzej Bagiński Nov 20, 2021 4:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The Covid Detector device has been added to the Register of rapid tests for the detection of SARS-CoV-2 virus in Austria. This instant contactless detector from ML System
eb has
eb has Dec 17, 2020 21:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There is nothing wrong with PFIZER . they just playing with us .by holding the Shers price down just To confuse us to Sell . Once they get all shares the prize will doubles which will happen after Christmas so Don't panic just hold your shares.
Tith Vicheth
Tith Vicheth Sep 15, 2020 5:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Price will be multiplied by 100 if it recover corona vaccine
Parveen Sabharwal
Parveen Sabharwal Sep 15, 2020 5:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just see how badly pfizer is performing Something wrong with the vaccine?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email